Oxygen and xenobiotic reductase activities of cytochrome P450.

The oxygen reductase and xenobiotic reductase activities of cytochrome P450 (P450) are reviewed. During the oxygen reductase activity of P450, molecular oxygen is reduced to superoxide anion radicals (O2-.) most likely by autooxidation of a P450 ferric-dioxyanion complex. The formation of reactive oxygen species (O2-., hydrogen peroxide, and, notably, hydroxyl free radicals) presents a potential toxication pathway, particularly when effective means of detoxication are lacking. Under anaerobic conditions, P450 may also be involved in the reduction of xenobiotics. During the xenobiotic reductase activity of P450, xenobiotics are reduced by the ferrous xenobiotic complex. After xenobiotic reduction by P450, xenobiotic free radicals are formed that are often capable of reacting directly with tissue macromolecules. Unfortunately, the compounds that are reductively activated by P450 have little structural similarity. The precise molecular mechanism underlying the xenobiotic reductase activity of P450 is, therefore, not yet fully understood. Moreover, description of the molecular mechanisms of xenobiotic and oxygen reduction reactions by P450 is limited by the lack of knowledge of the three-dimensional (3D) structure of the mammalian P450 proteins.

[1]  R. Nakagawa,et al.  Mutagenic/carcinogenic agents in indoor pollutants; the dinitropyrenes generated by kerosene heaters and fuel gas and liquefied petroleum gas burners. , 1985, Mutation research.

[2]  R. S. Beyer,et al.  Cytochromes P-450 and the activation and inactivation of mutagens and carcinogens. , 1986, Basic life sciences.

[3]  B. Ames,et al.  Mutagenicity of quinones: pathways of metabolic activation and detoxification. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. W. Anders,et al.  Metabolism of carbon tetrachloride to phosgene. , 1980, Life sciences.

[5]  E. Janzen,et al.  Spin trapping of free radical metabolites of carbon tetrachloride in vitro and in vivo: effect of acute ethanol administration. , 1992, Toxicology and applied pharmacology.

[6]  D. Fitz,et al.  Atmospheric reactions of polycyclic aromatic hydrocarbons: facile formation of mutagenic nitro derivatives. , 1978, Science.

[7]  M. J. Coon,et al.  Reductive beta-scission of the hydroperoxides of fatty acids and xenobiotics: role of alcohol-inducible cytochrome P-450. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Koop Oxidative and reductive metabolism by cytochrome P450 2E1 , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  T. Slater,et al.  Cytochrome P-450 distribution in rat liver and the effect of sodium phenobarbitone administration. , 1978, Chemico-biological interactions.

[10]  F. Guengerich,et al.  Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. , 1982, Biochemistry.

[11]  S. Wolff,et al.  Activity of nitro-polynuclear aromatic hydrocarbons in the sister chromatid exchange assay with and without metabolic activation. , 1982, Environmental mutagenesis.

[12]  E. Smuckler,et al.  Alterations of specific forms of cytochrome P-450 in rat liver during acute carbon tetrachloride intoxication. , 1981, Toxicology and applied pharmacology.

[13]  M. Ingelman-Sundberg,et al.  Cytochrome P-450-dependent formation of reactive oxygen radicals: isozyme-specific inhibition of P-450-mediated reduction of oxygen and carbon tetrachloride. , 1990, Xenobiotica; the fate of foreign compounds in biological systems.

[14]  S. Chatterjee,et al.  Membrane lipid peroxidation and its pathological consequences. , 1988, Indian journal of biochemistry & biophysics.

[15]  M. Ingelman-Sundberg,et al.  Hydroxyl-radical production and ethanol oxidation by liver microsomes isolated from ethanol-treated rats. , 1986, The Biochemical journal.

[16]  W. G. Levine Metabolism of azo dyes: implication for detoxication and activation. , 1991, Drug metabolism reviews.

[17]  M. Ingelman-Sundberg,et al.  Mechanisms of hydroxyl radical formation and ethanol oxidation by ethanol-inducible and other forms of rabbit liver microsomal cytochromes P-450. , 1984, The Journal of biological chemistry.

[18]  I. Roots,et al.  Possible control of hydrogen peroxide production and degradation in microsomes during mixed function oxidation reaction. , 1973, Biochemical and biophysical research communications.

[19]  W. G. Levine,et al.  Studies on the mechanism of reduction of azo dye carcinogens by rat liver microsomal cytochrome P-450. , 1989, Chemico-biological interactions.

[20]  R. Raag,et al.  Cytochrome P450cam: crystallography, oxygen activation, and electron transfer1 , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  A. Goldblum,et al.  Quantum chemical studies of anaerobic reductive metabolism of halothane by cytochrome P-450. , 1980, Chemico-biological interactions.

[22]  E. Jeffery,et al.  Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated r , 1983, Molecular pharmacology.

[23]  C. Cerniglia,et al.  The reduction of azo dyes by the intestinal microflora. , 1992, Critical reviews in microbiology.

[24]  H. Strobel,et al.  Identification and characterization of an NADPH-cytochrome P450 reductase derived peptide involved in binding to cytochrome P450. , 1991, Archives of biochemistry and biophysics.

[25]  E. Mimnaugh,et al.  A possible role for membrane lipid peroxidation in anthracycline nephrotoxicity. , 1986, Biochemical pharmacology.

[26]  T. Iyanagi,et al.  Interaction between NADPH-cytochrome P-450 reductase and cytochrome P-450 in the membrane of phosphatidylcholine vesicles. , 1979, Biochimica et biophysica acta.

[27]  Nico P. E. Vermeulen,et al.  A preliminary 3D model for cytochrome P450 2D6 constructed by homology model building , 1993, J. Comput. Aided Mol. Des..

[28]  T. Poulos,et al.  High-resolution crystal structure of cytochrome P450cam. , 1987, Journal of molecular biology.

[29]  L. Weiner,et al.  Redox transformations of quinone antitumor drugs in liver microsomes , 1988, FEBS letters.

[30]  H. Rouach,et al.  Implication of free radical mechanisms in ethanol-induced cellular injury. , 1992, Free radical biology & medicine.

[31]  P. Souček,et al.  Cytochromes P-450 in rats: structures, functions, properties and relevant human forms. , 1992, Xenobiotica; the fate of foreign compounds in biological systems.

[32]  H. Kuthan,et al.  Oxidase and oxygenase function of the microsomal cytochrome P450 monooxygenase system. , 1982, European journal of biochemistry.

[33]  M. Klingenberg Pigments of rat liver microsomes. , 1958, Archives of biochemistry and biophysics.

[34]  W. G. Levine,et al.  Two classes of azo dye reductase activity associated with rat liver microsomal cytochrome P-450. , 1991, Advances in experimental medicine and biology.

[35]  J. Malone,et al.  (+)- and (–)-Benzo[a]pyrene 7,8-oxide : synthesis, absolute stereochemistry, and stereochemical correlation with other mammalian metabolites of benzo[a]pyrene , 1980 .

[36]  J. Thompson,et al.  Reductive metabolism of 1,1,1,2-tetrachloroethane and related chloroethanes by rat liver microsomes. , 1984, Chemico-biological interactions.

[37]  P. O'Brien,et al.  Molecular mechanisms for bromotrichloromethane cytotoxicity in isolated rat hepatocytes. , 1990, Xenobiotica; the fate of foreign compounds in biological systems.

[38]  D. Jerina,et al.  Metabolism of chrysene and phenanthrene to bay-region diol epoxides by rat liver enzymes. , 1981, Molecular pharmacology.

[39]  D. Macphee,et al.  Crystal violet: a direct-acting frameshift mutagen whose mutagenicity is enhanced by mammalian metabolism. , 1984, Mutation research.

[40]  R. C. Garner,et al.  Nitrated polycyclic aromatic hydrocarbons: potent bacterial mutagens and stimulators of DNA repair synthesis in cultured human cells. , 1981, Carcinogenesis.

[41]  N. Vermeulen,et al.  One-electron reductive bioactivation of 2,3,5,6-tetramethylbenzoquinone by cytochrome P450. , 1992, Biochemical pharmacology.

[42]  C. S. Yang,et al.  The association between cytochrome P‐450 and NADPH‐cytochrome P‐450 reductase in microsomal membrane , 1975, FEBS letters.

[43]  J. Castro,et al.  Reductive metabolism and activation of benznidazole. , 1984, Biochemical pharmacology.

[44]  P. O'Brien Molecular mechanisms of quinone cytotoxicity. , 1991, Chemico-biological interactions.

[45]  I. Phillips,et al.  Quantification of NADPH: cytochrome P-450 reductase in liver microsomes by a specific radioimmunoassay technique. , 1983, The Biochemical journal.

[46]  D. J. Reed,et al.  Involvement of FMN and phenobarbital cytochrome P-450 in stimulating a one-electron reductive denitrosation of 1-(2-chloroethyl)-3-(cyclohexyl)-1-nitrosourea catalyzed by NADPH-cytochrome P-450 reductase. , 1983, The Journal of biological chemistry.

[47]  R. Mason,et al.  Two sites of azo reduction in the monooxygenase system. , 1988, Molecular pharmacology.

[48]  C. N. Martin,et al.  Rat liver microsomal azoreductase activity on four azo dyes derived from benzidine, 3,3'-dimethylbenzidine or 3,3'-dimethoxybenzidine. , 1981, Carcinogenesis.

[49]  R. Estabrook,et al.  Oxycytochrome P-450: its breakdown to superoxide for the formation of hydrogen peroxide. , 1979, Acta biologica et medica Germanica.

[50]  F. Guengerich,et al.  Purification of cytochrome P-450, NADPH-cytochrome P-450 reductase, and epoxide hydratase from a single preparation of rat liver microsomes. , 1980, Archives of biochemistry and biophysics.

[51]  W. D. Hewson,et al.  6 – Peroxidases, Catalases, and Chloroperoxidase , 1979 .

[52]  L. Koymans,et al.  Cytochromes P450: their active-site structure and mechanism of oxidation. , 1993, Drug metabolism reviews.

[53]  W. S. Brinigar,et al.  Solvent effects on reversible formation and oxidative stability of heme-oxygen complexes. , 1974, Journal of the American Chemical Society.

[54]  M. Terada,et al.  Mutagenicity of nitropyrenes in Chinese hamster V79 cells. , 1983, Gan.

[55]  Formation of superoxide ion via one-electron transfer from electron donors to singlet oxygen , 1983 .

[56]  D. Nebert,et al.  Evolution of the P450 gene superfamily: animal-plant 'warfare', molecular drive and human genetic differences in drug oxidation. , 1990, Trends in genetics : TIG.

[57]  S. Sligar,et al.  Spin state control of the hepatic cytochrome P450 redox potential. , 1979, Biochemical and biophysical research communications.

[58]  Mark T. Fisher,et al.  Control of heme protein redox potential and reduction rate: linear free energy relation between potential and ferric spin state equilibrium , 1985 .

[59]  T. Lampidis,et al.  Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells. , 1985, The Journal of biological chemistry.

[60]  Duane F. Bruley,et al.  Oxygen transport to tissue , 1973 .

[61]  C. Ioannides,et al.  Molecular orbital studies of oxygen activation and mechanisms of cytochromes P-450-mediated oxidative metabolism of xenobiotics. , 1989, Chemico-biological interactions.

[62]  R. Estabrook,et al.  ACTIVE OXYGEN—FACT OR FANCY , 1977 .

[63]  C. Cerniglia,et al.  Biotransformation of gentian violet to leucogentian violet by human, rat, and chicken intestinal microflora. , 1984, Drug metabolism and disposition: the biological fate of chemicals.

[64]  N. Harada,et al.  Participation of cytochrome P-450 in the reduction of nitro compounds by rat liver microsomes. , 1980, Journal of biochemistry.

[65]  E. Testai,et al.  Biochemical alterations elicited in rat liver microsomes by oxidation and reduction products of chloroform metabolism. , 1986, Chemico-biological interactions.

[66]  B C Finzel,et al.  Crystal structure of substrate-free Pseudomonas putida cytochrome P-450. , 1986, Biochemistry.

[67]  S. Sligar,et al.  Kinetics of cytochrome P-450 reduction: evidence for faster reduction of the high-spin ferric state. , 1985, Biochemistry.

[68]  Guengerich Fp Oxidation-reduction properties of rat liver cytochromes P-450 and NADPH-cytochrome P-450 reductase related to catalysis in reconstituted systems , 1983 .

[69]  A. Y. Lu,et al.  Studies on the association of cytochrome P-450 and NADPH-cytochrome c reductase during catalysis in a reconstituted hydroxylating system. , 1979, The Journal of biological chemistry.

[70]  J. Schenkman,et al.  The cytochrome P450 2B4-NADPH cytochrome P450 reductase electron transfer complex is not formed by charge-pairing. , 1992, The Journal of biological chemistry.

[71]  R. Estabrook,et al.  Cytochrome P-450—Its Role in Oxygen Activation for Drug Metabolism , 1977 .

[72]  I. Fridovich,et al.  Superoxide dismutase: the first twenty years (1968-1988). , 1988, Free radical biology & medicine.

[73]  S A van Acker,et al.  A predictive model for substrates of cytochrome P450-debrisoquine (2D6). , 1992, Chemical research in toxicology.

[74]  D. Gustafson,et al.  Role of xanthine oxidase in the potentiation of doxorubicin-induced cardiotoxicity by mitomycin C. , 1991, Cancer communications.

[75]  A. Bast Is formation of reactive oxygen by cytochrome P-450 perilous and predictable? , 1986 .

[76]  M. J. Coon,et al.  Oxygen activation by cytochrome P-450. , 1980, Annual review of biochemistry.

[77]  John T. Groves,et al.  Reactive iron porphyrin derivatives related to the catalytic cycles of cytochrome P-450 and peroxidase. Studies of the mechanism of oxygen activation , 1988 .

[78]  A. Benson,et al.  Biochemical determinants of Adriamycin toxicity in mouse liver, heart and intestine. , 1992, Biochemical pharmacology.

[79]  W. Backes,et al.  Cytochrome P-450 LM2 reduction. Substrate effects on the rate of reductase-LM2 association. , 1989, The Journal of biological chemistry.

[80]  D. Jerina,et al.  Absolute configuration of the trans-9,10-dihydrodiol metabolite of the carcinogen benzo[a]pyrene , 1982 .

[81]  N. Vermeulen,et al.  Role of hepatic microsomal and purified cytochrome P-450 in one-electron reduction of two quinone imines and concomitant reduction of molecular oxygen. , 1987, Biochemical pharmacology.

[82]  C. Chiang,et al.  Evidence for the stability and cytochrome P450 specificity of the phenobarbital-induced reductive halothane-cytochrome P450 complex formed in rat hepatic microsomes. , 1991, Biochemical pharmacology.

[83]  M. Manno,et al.  Suicidal inactivation of human cytochrome P-450 by carbon tetrachloride and halothane in vitro. , 1992, Pharmacology & toxicology.

[84]  W. Levin,et al.  Studies on the induction of CO-binding pigments in liver microsomes by phenobarbital and 3-methylcholanthrene. , 1967, Biochemical and biophysical research communications.

[85]  D. Jerina,et al.  Chemical modification and inactivation of rat liver microsomal cytochrome P-450c by 2-bromo-4'-nitroacetophenone. , 1986, The Journal of biological chemistry.

[86]  D. Jerina,et al.  Mechanism of inactivation of rat liver microsomal cytochrome P-450c by 2-bromo-4'-nitroacetophenone. , 1986, The Journal of biological chemistry.

[87]  S. Shibata,et al.  Reduction of 2,4-dinitrotoluene by Wistar rat liver microsomal and cytosol fractions. , 1984, Toxicology and applied pharmacology.

[88]  J. Doroshow Role of hydrogen peroxide and hydroxyl radical formation in the killing of Ehrlich tumor cells by anticancer quinones. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[89]  H. Taniguchi,et al.  Role of the electron transfer system in microsomal drug monooxygenase reaction catalyzed by cytochrome P-450. , 1984, Archives of biochemistry and biophysics.

[90]  V. Ullrich,et al.  Uncoupling of monooxygenation and electron transport by fluorocarbons in liver microsomes. , 1971, European journal of biochemistry.

[91]  B. Zielińska,et al.  A Possible formation pathway for the 2-nitrofluoranthene observed in ambient particulate organic matter , 1986 .

[92]  S. Nesnow,et al.  Inhibition of benzo(A)pyrene monooxygenase by α-naphthoflavone may be partially mediated by the metabolite9-hydroxy-α-naphthoflavone , 1982 .

[93]  W. Nastainczyk,et al.  Effect of oxygen concentration on the reaction of halothane with cytochrome P450 in liver microsomes and isolated perfused rat liver. , 1978, Biochemical Pharmacology.

[94]  Association of hydrophobic substances with hemin. Characterization of the reverse type I binding spectrum and its relationship to cytochrome P-450. , 1986, Biochemical pharmacology.

[95]  T. Iyanagi,et al.  Rate-limiting step in the reconstituted microsomal drug hydroxylase system. , 1977, Journal of biochemistry.

[96]  J. Gillette,et al.  Mechanism of p-nitrobenzoate reduction in liver: the possible role oc cytochrome P-450 in liver microsomes. , 1968, Molecular pharmacology.

[97]  P. R. Montellano Cytochrome P-450 , 1986, Springer US.

[98]  N. Bachur,et al.  NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[99]  S. Sligar,et al.  Cytochrome P-450cam and Other Bacterial P-450 Enzymes , 1986 .

[100]  K. Danenberg,et al.  NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. , 1992, Cancer research.

[101]  M. Ingelman-Sundberg,et al.  Ligand-dependent maintenance of ethanol-inducible cytochrome P-450 in primary rat hepatocyte cell cultures. , 1988, Biochemical and biophysical research communications.

[102]  H. Rosenkranz,et al.  The extraordinary mutagenicity of nitropyrenes in bacteria. , 1981, Mutation research.

[103]  G. Powis Free radical formation by antitumor quinones. , 1989, Free radical biology & medicine.

[104]  A. Y. Lu,et al.  Electroimmunochemical quantitation of cytochrome P-450, cytochrome P-448, and epoxide hydrolase in rat liver microsomes. , 1981, The Journal of biological chemistry.

[105]  M. Ingelman-Sundberg,et al.  Carbon tetrachloride‐induced lipid peroxidation dependent on an ethanol‐inducible form of rabbit liver microsomal cytochrome P‐450 , 1985, FEBS letters.

[106]  D. T. Sawyer,et al.  On the chemical reactivity of superoxide ion , 1978 .

[107]  M. D. Corbett,et al.  Metabolism of 4-Chloronitrobenzene by the Yeast Rhodosporidium sp , 1981, Applied and environmental microbiology.

[108]  A. Stoppani,et al.  Inhibition of microsomal lipid peroxidation and cytochrome P-450-catalyzed reactions by nitrofuran compounds. , 1991, Free radical research communications.

[109]  A. Elgoyhen,et al.  Serotonin uptake inhibitors and the prejunctional effects of serotonin on peripheral sympathetic nerves. , 1986, Life sciences.

[110]  S. Sligar,et al.  Metabolic switching in cytochrome P-450cam: Deuterium isotope effects on regiospecificity and the monooxygenase/oxidase ratio , 1987 .

[111]  S. Kitamura,et al.  Azoreductase activity of liver aldehyde oxidase. , 1983, Chemical & pharmaceutical bulletin.

[112]  S. Martinis,et al.  Crystal structure of the cytochrome P-450CAM active site mutant Thr252Ala. , 1991, Biochemistry.

[113]  W. G. Levine,et al.  Role of electronic factors in binding and reduction of azo dyes by hepatic microsomes. , 1992, The Journal of pharmacology and experimental therapeutics.

[114]  A. Stier TRIFLUOROACETIC ACID AS METABOLITE OF HALOTHANE. , 1964, Biochemical pharmacology.

[115]  Seiki Mukai,et al.  Volatile Metabolites of Halothane in the Rabbit , 1977, Anesthesiology.

[116]  C. Auclair,et al.  Superoxide anion production by liver microsomes from phenobarbital treated rat. , 1978, Biochemical pharmacology.

[117]  H. Strobel,et al.  Isolation of the membrane-binding peptide of NADPH-cytochrome P-450 reductase. Characterization of the peptide and its role in the interaction of reductase with cytochrome P-450. , 1981, The Journal of biological chemistry.

[118]  V. Ullrich,et al.  Metabolism and cytochrome P-450 binding spectra of (+)- and (-)-hexobarbital in rat liver microsomes. , 1969, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[119]  M. J. Coon,et al.  Spectral intermediates in the reaction of oxygen with purified liver microsomal cytochrome P-450. , 1976, Biochemical and biophysical research communications.

[120]  W. G. Levine,et al.  Azoreduction of N,N-dimethyl-4-aminoazobenzene (DAB) by rat hepatic microsomes. Selective induction by clofibrate. , 1986, Drug Metabolism And Disposition.

[121]  M. J. Coon,et al.  Structural features of liver microsomal NADPH-cytochrome P-450 reductase. Hydrophobic domain, hydrophilic domain, and connecting region. , 1982, The Journal of biological chemistry.

[122]  O. Strubelt Alcohol Potentiation of Liver Injury , 1984 .

[123]  M. Harms-Ringdahl,et al.  Nuclear membrane lipid peroxidation products bind to nuclear macromolecules. , 1989, Archives of biochemistry and biophysics.

[124]  B. Testa,et al.  Inhibitors of Cytochrome P-450s and their mechanism of action. , 1981, Drug metabolism reviews.

[125]  N. Vermeulen,et al.  Disposition of hexobarbital: 15 years of an intriguing model substrate. , 1988, Drug metabolism reviews.

[126]  J. Lipscomb,et al.  The role of putidaredoxin and P450 cam in methylene hydroxylation. , 1972, The Journal of biological chemistry.

[127]  R. V. Van dyke,et al.  The formation of chlorobenzene and benzene by the reductive metabolism of lindane in rat liver microsomes. , 1985, Archives of biochemistry and biophysics.

[128]  J. Schenkman,et al.  Status of the cytochrome P-450 cycle , 1981 .

[129]  J. R. Brown,et al.  Involvement of hydroxyl radical formation and DNA strand breakage in the cytotoxicity of anthraquinone antitumour agents. , 1990, Free radical research communications.

[130]  R. Mason,et al.  Spin-trapping and direct electron spin resonance investigations of the redox metabolism of quinone anticancer drugs. , 1980, Biochimica et biophysica acta.

[131]  R. Estabrook,et al.  Spectral studies of drug interaction with hepatic microsomal cytochrome. , 1967, Molecular pharmacology.

[132]  R. O. Recknagel,et al.  Evaluation of a role for phosgene production in the hepatotoxic mechanism of action of carbon tetrachloride and bromotrichloromethane. , 1982, Toxicology and applied pharmacology.

[133]  B. James,et al.  One-electron electrochemical reduction of a ferrous porphyrin dioxygen complex , 1981 .

[134]  T. Slater,et al.  The metabolism of halothane by hepatocytes: a comparison between free radical spin trapping and lipid peroxidation in relation to cell damage. , 1983, Chemico-biological interactions.

[135]  B. Sinha Free radicals in anticancer drug pharmacology. , 1989, Chemico-biological interactions.

[136]  F. Guengerich Cytochrome P450: advances and prospects , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[137]  M. Ingelman-Sundberg,et al.  Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). , 1989, Biochemical pharmacology.

[138]  J. Farber,et al.  Mechanisms of cell injury with hepatotoxic chemicals. , 1984, Pharmacological reviews.

[139]  W. Koppenol,et al.  The kinetics of the reduction of cytochrome c by the superoxide anion radical. , 1976, Biochimica et biophysica acta.

[140]  S. D. Black,et al.  Membrane topology of mammalian cytochromes P-450 from liver endoplasmic reticulum. Determination by trypsinolysis of phenobarbital-treated microsomes. , 1989, The Journal of biological chemistry.

[141]  R. Mason,et al.  Microsomal reduction of gentian violet. Evidence for cytochrome P-450-catalyzed free radical formation. , 1982, Molecular pharmacology.

[142]  L. J. King,et al.  The degradation of haem by carbon tetrachloride: metabolic activation requires a free axial coordination site on the haem iron and electron donation. , 1989, Xenobiotica; the fate of foreign compounds in biological systems.

[143]  M. Ingelman-Sundberg,et al.  Effect of in vivo chromate, acetone and combined treatment on rat liver in vitro microsomal chromium(VI) reductive activity and on cytochrome P450 expression. , 1991, Pharmacology & toxicology.

[144]  S. D. Black Membrane topology of the mammalian P450 cytochromes , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[145]  G. Powis,et al.  Metabolism and reactions of quinoid anticancer agents. , 1987, Pharmacology & therapeutics.

[146]  E. Frolova,et al.  Hydroxyl radical generation and DNA strand scission mediated by natural anticancer and synthetic quinones , 1989, FEBS letters.

[147]  R. Mason,et al.  Microsomal reduction of 3-amino-1,2,4-benzotriazine 1,4-dioxide to a free radical. , 1991, Molecular pharmacology.

[148]  J. Gutteridge Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides , 1986, FEBS letters.

[149]  N. Vermeulen,et al.  Cytochrome P450 2B1-mediated one-electron reduction of adriamycin: a study with rat liver microsomes and purified enzymes. , 1993, Molecular pharmacology.

[150]  M. Rogawski,et al.  Selectivity in the inhibition of mammalian cytochromes P-450 by chemical agents. , 1990, Pharmacological reviews.

[151]  W. L. Weller,et al.  Metabolic Fate of Hexobarbital (HBj , 1972 .

[152]  R. Mason,et al.  Inhibition of azoreductase by oxygen. The role of the azo anion free radical metabolite in the reduction of oxygen to superoxide. , 1978, Molecular pharmacology.

[153]  W. G. Levine,et al.  A novel application of cyclic voltammetry for direct investigation of metabolic intermediates in microsomal azo reduction. , 1991, Chemical research in toxicology.

[154]  N. Vermeulen,et al.  Reductase and oxidase activity of rat liver cytochrome P450 with 2,3,5,6-tetramethylbenzoquinone as substrate. , 1992, Chemico-biological interactions.

[155]  S. Sligar,et al.  Metabolic activation of mitomycin C by liver microsomes and nuclei. , 1982, Biochemical pharmacology.

[156]  S. Kitamura,et al.  Reductive metabolism of aromatic nitro compounds including carcinogens by rabbit liver preparations. , 1986, Cancer research.

[157]  R. Ebel,et al.  Temperature dependence of cytochrome P-450 reduction. A model for NADPH-cytochrome P-450 reductase:cytochrome P-450 interaction. , 1976, The Journal of biological chemistry.

[158]  T. Takano,et al.  Interaction of 1,1,1-trichloroethane with the mixed-function oxidation system in rat liver microsomes. , 1988, Xenobiotica; the fate of foreign compounds in biological systems.

[159]  T. Tsong,et al.  Rapid conformational changes of cytochrome P-450: effect of dimyristoyl lecithin. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[160]  S. Sligar,et al.  Oxygenase-catalyzed biological hydroxylations. , 1975, Annual review of biochemistry.

[161]  A. Y. Lu,et al.  Rat liver cytosolic azoreductase. Electron transport properties and the mechanism of dicumarol inhibition of the purified enzyme. , 1979, The Journal of biological chemistry.

[162]  W. Backes,et al.  Relationship between the rate of reductase-cytochrome P450 complex formation and the rate of first electron transfer. , 1992, Archives of biochemistry and biophysics.

[163]  B. Zielińska,et al.  The mutagenicity of 2-nitrofluoranthene and its in vitro hepatic metabolites. , 1987, Mutation research.

[164]  N. Vermeulen,et al.  One-electron reduction of mitomycin c by rat liver: role of cytochrome P-450 and NADPH-cytochrome P-450 reductase. , 1990, Xenobiotica; the fate of foreign compounds in biological systems.

[165]  R. Mason,et al.  In vivo radical trapping and biliary secretion of radical adducts of carbon tetrachloride-derived free radical metabolites. , 1988, Drug metabolism and disposition: the biological fate of chemicals.

[166]  M. J. Coon,et al.  On the stoichiometry of the oxidase and monooxygenase reactions catalyzed by liver microsomal cytochrome P-450. Products of oxygen reduction. , 1984, The Journal of biological chemistry.

[167]  N. D'souza,et al.  Hepatic antioxidant enzymes and lipid peroxidation in carbon tetrachloride-induced liver cirrhosis in rats. , 1988, Biochemical medicine and metabolic biology.

[168]  R. Raag,et al.  Crystal structure of the carbon monoxide-substrate-cytochrome P-450CAM ternary complex. , 1989, Biochemistry.

[169]  T. Noll,et al.  The crucial role of low steady state oxygen partial pressures in haloalkane free-radical-mediated lipid peroxidation. Possible implications in haloalkane liver injury. , 1986, Biochemical pharmacology.

[170]  P. O'Brien,et al.  Hydroperoxide catalyzed liver microsomal aromatic hydroxylation reactions involving cytochrome P-450. , 1974, Biochemical and biophysical research communications.

[171]  D. Nelson,et al.  On the membrane topology of vertebrate cytochrome P-450 proteins. , 1988, The Journal of biological chemistry.

[172]  G. Powis,et al.  Pulse radiolysis studies of antitumor quinones: radical lifetimes, reactivity with oxygen, and one-electron reduction potentials. , 1981, Archives of biochemistry and biophysics.

[173]  M. Ingelman-Sundberg,et al.  Human liver microsomal cytochrome P-450IIE1. Immunological evaluation of its contribution to microsomal ethanol oxidation, carbon tetrachloride reduction and NADPH oxidase activity. , 1989, Biochemical pharmacology.

[174]  S. Moreno,et al.  Metabolism and mode of action of gentian violet. , 1988, Memorias do Instituto Oswaldo Cruz.

[175]  B. Puschendorf,et al.  Effects of the lipidperoxidation product 4-hydroxynonenal and related aldehydes on proliferation and viability of cultured Ehrlich ascites tumor cells. , 1985, Biochemical pharmacology.

[176]  M. J. Coon,et al.  Identification of the high and low potential flavins of liver microsomal NADPH-cytochrome P-450 reductase. , 1978, The Journal of biological chemistry.

[177]  M. Kawahara,et al.  Halothane‐induced hepatic microsomal lipid peroxidation in guinea pigs and rats , 1989, Journal of applied toxicology : JAT.

[178]  M. J. Coon,et al.  The P450 superfamily: updated listing of all genes and recommended nomenclature for the chromosomal loci. , 1989, DNA.

[179]  L. Weiner,et al.  Microsomal and photochemical oxidation and reduction of 1-piperidinoanthraquinone. , 1982, Biochimica et biophysica acta.

[180]  M. Ingelman-Sundberg,et al.  Mechanisms of lipid peroxidation dependent upon cytochrome P-450 LM2. , 1986, European journal of biochemistry.

[181]  D. Jerina,et al.  Stereoselectivity of rat liver cytochrome P-450c on formation of benzo[a]pyrene 4,5-oxide. , 1981, Biochemical and biophysical research communications.

[182]  M. J. Coon,et al.  Role of a hydrophobic polypeptide in the N-terminal region of NADPH-cytochrome P-450 reductase in complex formation with P-450LM. , 1979, Biochemical and biophysical research communications.

[183]  P. McCay,et al.  Specificity of a phenobarbital-induced cytochrome P-450 for metabolism of carbon tetrachloride to the trichloromethyl radical. , 1982, Biochemical pharmacology.

[184]  A. Bast,et al.  Inhibition of mono-oxygenase and oxidase activity of rat-hepatic cytochrome P-450 by H2-receptor blockers. , 1984, Xenobiotica; the fate of foreign compounds in biological systems.

[185]  D. Jerina,et al.  Stereoselective formation of benz[a]anthracene (+)-(5S,6R)-oxide and (+)-(8R,9S)-oxide by a highly purified and reconstituted system containing cytochrome P-450c. , 1982, Biochemical and biophysical research communications.

[186]  F. Kadlubar,et al.  Microsomal-catalyzed hydroperoxide-dependent C-oxidation of amines. , 1973, Biochemical and biophysical research communications.

[187]  F. Gonzalez,et al.  The induction of a specific form of cytochrome P-450 (P-450j) by fasting. , 1987, Biochemical and biophysical research communications.

[188]  A. D. McLean,et al.  Theoretical investigations of the anaerobic reduction of halogenated alkanes by cytochrome P 450. 1. Structures, inversion barriers, and heats of formation of halomethyl radicals , 1987 .

[189]  H. Strobel,et al.  Purified NADPH cytochrome P-450 reductase. Interaction with hepatic microsomes and phospholipid vesicles. , 1979, The Journal of biological chemistry.

[190]  J. Castro,et al.  Early destruction of cytochrome P-450 in testis of carbon tetrachloride poisoned rats. , 1978, Toxicology.

[191]  T Shimizu,et al.  Role of Glu318 at the putative distal site in the catalytic function of cytochrome P450d. , 1992, Biochemistry.

[192]  M. Kessler,et al.  Homeostasis of oxygen supply in liver and kidney. , 1973, Advances in experimental medicine and biology.

[193]  T. Kamataki,et al.  Participation of cytochrome P-450 in reductive metabolism of 1-nitropyrene by rat liver microsomes. , 1984, Cancer research.

[194]  T. Omura,et al.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. , 1964, The Journal of biological chemistry.

[195]  P. O'Brien,et al.  Toxicity of nitrobenzene compounds towards isolated hepatocytes: dependence on reduction potential. , 1990, Xenobiotica; the fate of foreign compounds in biological systems.

[196]  S. Sligar,et al.  Kinetics of hepatic cytochrome P-450 reduction: correlation with spin state of the ferric heme. , 1982, Biochemistry.

[197]  W. G. Levine,et al.  Mechanism of azoreduction of dimethylaminoazobenzene by rat liver NADPH-cytochrome P-450 reductase and partially purified cytochrome P-450. Oxygen and carbon monoxide sensitivity and stimulation by FAD and FMN. , 1988, Drug metabolism and disposition: the biological fate of chemicals.

[198]  H. de Groot,et al.  Self-catalysed, O2-independent inactivation of NADPH- or dithionite-reduced microsomal cytochrome P-450 by carbon tetrachloride. , 1981, Biochemical pharmacology.

[199]  T. Tanaka,et al.  Superoxide anion is the initial product in the hydrogen peroxide formation catalyzed by NADPH oxidase in porcine thyroid plasma membrane. , 1989, The Journal of biological chemistry.

[200]  G. Powis,et al.  Relationship of the single-electron reduction potential of quinones to their reduction by flavoproteins. , 1980, Biochemical pharmacology.

[201]  R. Estabrook,et al.  On the inhibitory action of mersalyl on microsomal drug oxidation: a rigid organization of the electron transport chain. , 1971, Archives of biochemistry and biophysics.

[202]  J. Gillette,et al.  Studies on the mechanism of action of mammalian hepatic azoreductase. II. The effects of phenobarbital and 3-methylcholanthrene on carbon monoxide sensitive and insensitive azoreductase activities. , 1967, Biochemical pharmacology.

[203]  S. Kawato,et al.  Rotation of cytochrome P-450. Complex formation of cytochrome P-450 with NADPH-cytochrome P-450 reductase in liposomes demonstrated by combining protein rotation with antibody-induced cross-linking. , 1983, The Journal of biological chemistry.

[204]  W. G. Levine,et al.  Multiple mechanisms in hepatic microsomal azoreduction. , 1992, Xenobiotica; the fate of foreign compounds in biological systems.

[205]  C. Villee,et al.  Early role during chemical evolution for cytochrome P450 in oxygen detoxification , 1975, Nature.

[206]  J. H. van Lenthe,et al.  A theoretical study on the metabolic activation of paracetamol by cytochrome P-450: indications for a uniform oxidation mechanism. , 1988, Chemical research in toxicology.

[207]  S. Sligar,et al.  Reduction kinetics of purified rat liver cytochrome P-450. Evidence for a sequential reaction mechanism dependent on the hemoprotein spin state. , 1984, Biochemistry.

[208]  H. Griffiths,et al.  Reactive oxygen species induce antigenic changes in DNA , 1989, FEBS letters.

[209]  A. Y. Lu,et al.  The Topology of the Mammalian Cytochrome P-450 Active Site , 1986 .